A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

NCT07626515 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

COMBINATION_PRODUCT: Enicepatide
COMBINATION_PRODUCT: Placebo

Sponsor

Hoffmann-La Roche